Macrolide – induced clinically relevant drug interactions with cytochrome P‐450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin
- 1 October 2000
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 50 (4) , 285-295
- https://doi.org/10.1046/j.1365-2125.2000.00261.x
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Macrolide AntibacterialsDrug Safety, 1995
- Metabolism of Drugs by Cytochrome P450 3A IsoformsClinical Pharmacokinetics, 1995
- Inhibition of Terfenadine MetabolismClinical Pharmacokinetics, 1994
- Steady‐State Pharmacokinetics of Theophylline in COPD Patients Treated With DirithromycinThe Journal of Clinical Pharmacology, 1993
- Clinical Pharmacokinetics of Newer Antibacterial Agents in Liver DiseaseClinical Pharmacokinetics, 1993
- Pharmacokinetic Drug Interactions of MacrolidesClinical Pharmacokinetics, 1992
- Pharmacokinetic Drug Interactions with Cyclosporin (Part I)1Clinical Pharmacokinetics, 1990
- INHIBITION OF THEOPHYLLINE METABOLISM BY INTERFERONThe Lancet, 1987
- Effect of erythromycin on theophylline kineticsJournal of Allergy and Clinical Immunology, 1981
- Age as a determinant of sensitivity to warfarin.British Journal of Clinical Pharmacology, 1977